{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:15:01Z","timestamp":1790115301895,"version":"4.0.1"},"reference-count":94,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Renal cell carcinoma, an aggressive malignancy, is often incidentally diagnosed. The patient remains asymptomatic to the late stage of the disease, when the local or distant metastases are already present. Surgical treatment remains the choice for these patients, although the plan must adapt to the characteristics of the patients and the extension of the neoplasm. Systemic therapy is sometimes needed. It includes immunotherapy, target therapy, or both, with a high level of toxicity. Cardiac biomarkers have prognosis and monitoring values in this setting. Their role in postoperative identification of myocardial injury and heart failure already have been demonstrated, as well as their importance in preoperative evaluation from the cardiac point of view and the progression of renal cancer. The cardiac biomarkers are also part of the new cardio-oncologic approach to establishing and monitoring systemic therapy. They are complementary tests for assessment of the baseline toxicity risk and tools to guide therapy. The goal must be to continue the treatment as long as possible with the initiation and optimisation of the cardiological treatment. Cardiac atrial biomarkers are reported to have also antitumoral and anti-inflammatory properties. This review aims to present the role of cardiac biomarkers in the multidisciplinary management of renal cell carcinoma patients.<\/jats:p>","DOI":"10.3390\/diagnostics13111912","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T07:21:51Z","timestamp":1685517711000},"page":"1912","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of the Cardiac Biomarkers in the Renal Cell Carcinoma Multidisciplinary Management"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2944-6527","authenticated-orcid":false,"given":"Anca","family":"Dr\u0103gan","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Anaesthesiology and Intensive Care, Prof. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 258 Fundeni Road, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanel","family":"Sinescu","sequence":"additional","affiliation":[{"name":"Department of Urological Surgery, Dialysis and Kidney Transplantation, Fundeni Clinical Institute, 258 Fundeni Road, 022328 Bucharest, Romania"},{"name":"Department of Uronephrology, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Makino, T., Kadomoto, S., Izumi, K., and Mizokami, A. (2022). Epidemiology and Prevention of Renal Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14164059"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2337\/dc17-2518","article-title":"Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies","volume":"41","author":"Graff","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.juro.2013.04.130","article-title":"Risk factors for renal cell carcinoma in the vital study","volume":"190","author":"Macleod","year":"2013","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.ackd.2021.10.008","article-title":"Renal Cell Cancer and Chronic Kidney Disease","volume":"28","author":"Saly","year":"2021","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eururo.2022.09.026","article-title":"A renewal of the TNM Staging System for patients with Renal Cancer to comply with current decision-making: Proposal from the European Association of Urology Guidelines Panel","volume":"83","author":"Capitanio","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tabbara, M.M., Gonz\u00e1lez, J., Martucci, M., and Ciancio, G. (2023). Current Approaches in Surgical and Immunotherapy-Based Management of Renal Cell Carcinoma with Tumor Thrombus. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010204"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1002\/cncr.32993","article-title":"Personalizing preoperative risk stratification and refining patient selection for cytoreductive nephrectomy in metastatic renal cell carcinoma","volume":"126","author":"Psutka","year":"2020","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21037\/atm.2016.05.19","article-title":"An historical approach to the diagnostic biomarkers of acute coronary syndrome","volume":"4","author":"Danese","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/2001010a0","article-title":"Third component participating in the superprecipitation of \u2018natural actomyosin\u2019","volume":"200","author":"Ebashi","year":"1963","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/oxfordjournals.jbchem.a128628","article-title":"Troponin as the Ca++-receptive protein in the contractile system","volume":"62","author":"Ebashi","year":"1967","journal-title":"J. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0079-6107(68)90023-0","article-title":"Calcium ion and muscle contraction","volume":"18","author":"Ebashi","year":"1968","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/S0021-9258(18)62075-7","article-title":"Reconstitution of troponin activity from three protein components","volume":"246","author":"Greaser","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_14","first-page":"9713326","article-title":"High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications","volume":"2022","author":"Lazar","year":"2022","journal-title":"Dis. Mrk."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11739-017-1612-1","article-title":"Cardiac biomarkers of acute coronary syndrome: From history to high-sensitivity cardiac troponin","volume":"12","author":"Garg","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_18","first-page":"102","article-title":"High-sensitive cardiac troponin T","volume":"10","author":"Xu","year":"2013","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.jacc.2011.01.029","article-title":"Pathobiology of troponin elevations: Do elevations occur with myocardial ischemia as well as necrosis?","volume":"57","author":"White","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1515\/cclm-2016-0933","article-title":"The 99th percentile of reference population for cTnI and cTnT assay: Methodology, pathophysiology and clinical implications","volume":"55","author":"Clerico","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1515\/cclm-2022-1285","article-title":"Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: Analytical considerations and clinical relevance","volume":"61","author":"Clerico","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-142-9-200505030-00015","article-title":"Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded","volume":"142","author":"Jeremias","year":"2005","journal-title":"Ann. Intern Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/clc.23486","article-title":"Cardiac troponin I predicts clinical outcome of patients with cancer at emergency department","volume":"43","author":"Park","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1002\/ehf2.13515","article-title":"High-sensitivity cardiac troponin T determines all-cause mortality in cancer patients: A single-centre cohort study","volume":"8","author":"Finke","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality","volume":"101","author":"Pavo","year":"2015","journal-title":"Heart"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S4282","DOI":"10.21037\/jtd.2018.08.15","article-title":"Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity","volume":"10","author":"Michel","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hua, Y.B., Li, X., and Wang, D.X. (2021). Prevalence and risk factors of myocardial and acute kidney injury following radical nephrectomy with vena cava thrombectomy: A retrospective cohort study. BMC Anesthesiol., 21.","DOI":"10.1186\/s12871-021-01462-y"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1200\/JCO.21.01806","article-title":"Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients with Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial","volume":"40","author":"Rini","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in Patients Treated With Immune Checkpoint Inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bj.2021.06.007","article-title":"Modified natriuretic peptides and their potential roles in cancer treatment","volume":"45","author":"Xu","year":"2022","journal-title":"Biomed. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.coc.0000256101.04404.b0","article-title":"Cancer Patients with Markedly Elevated B-Type Natriuretic Peptide May Not Have Volume Overload","volume":"30","author":"Burjonroppa","year":"2007","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Papazisis, K.T., Kontovinis, L.F., Papandreou, C.N., Kouvatseas, G., Lafaras, C., Antonakis, E., Christopoulou, M., Andreadis, C., Mouratidou, D., and Kortsaris, A.H. (2010). Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-489"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tu\u00f1\u00f3n, J., Higueras, J., Tar\u00edn, N., Crist\u00f3bal, C., Lorenzo, \u00d3., Blanco-Colio, L., Mart\u00edn-Ventura, J.L., Huelmos, A., Alonso, J., and Ace\u00f1a, \u00c1. (2015). N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126741"},{"key":"ref_36","first-page":"13","article-title":"Global Longitudinal Strain: Is It Time to Change the Preoperative Cardiac Assessment of Oncology Patients?","volume":"9","author":"Shehata","year":"2021","journal-title":"Oncology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ejhf.632","article-title":"Global longitudinal strain: The best biomarker for predicting prognosis in heart failure?","volume":"18","author":"Haugaa","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0735-1097(19)32120-5","article-title":"Precision and stability of parameters for assessment of left ventricular systolic function in clinical trials: Lessons from the SUCCOUR trial","volume":"73","author":"Negishi","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Semeraro, G.C., Cipolla, C.M., and Cardinale, D.M. (2021). Role of Cardiac Biomarkers in Cancer Patients. Cancers, 13.","DOI":"10.3390\/cancers13215426"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/cncr.33788","article-title":"Evolution of risk stratification systems is critical for improving patient selection for cytoreductive nephrectomy","volume":"127","author":"Esdaille","year":"2021","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/bjaceaccp\/mkv022","article-title":"Anaesthesia for nephrectomy","volume":"16","author":"Chapman","year":"2016","journal-title":"BJA Educ."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17562872221084847","DOI":"10.1177\/17562872221084847","article-title":"Major adverse cardiovascular events following partial nephrectomy: A procedure-specific risk index","volume":"14","author":"Nasrallah","year":"2022","journal-title":"Adv. Urol."},{"key":"ref_45","first-page":"2512","article-title":"Association of Echocardiography Before Major Elective Non-Cardiac Surgery with Improved Postoperative Outcomes\u2014Possible Implications for Patient Care","volume":"83","author":"Kusunose","year":"2019","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jacc.2009.06.028","article-title":"Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies","volume":"54","author":"Karthikeyan","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jacc.2013.08.1630","article-title":"The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: A systematic review and individual patient data meta-analysis","volume":"63","author":"Rodseth","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Dr\u0103gan, A., and Sinescu, I. (2023). AKI3-Risk Predictors and Scores in Radical Nephrectomy with High Thrombectomy under Extracorporeal Circulation for Renal Cell Carcinoma with Supradiaphragmatic Inferior Vena Cava\/Right Atrial Thrombus: A Single-Centre Retrospective Study. Medicina, 59.","DOI":"10.3390\/medicina59020386"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bando, S., Soeki, T., Matsuura, T., Tobiume, T., Ise, T., Kusunose, K., Yamaguchi, K., Yagi, S., Fukuda, D., and Iwase, T. (2017). Plasma brain natriuretic peptide levels are elevated in patients with cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178607"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e000666","DOI":"10.1136\/openhrt-2017-000666","article-title":"Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer","volume":"5","author":"Kamai","year":"2018","journal-title":"Open Heart"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s13063-022-06701-2","article-title":"PRE-OPerative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: Protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO)","volume":"23","author":"Kim","year":"2022","journal-title":"Trials"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2023.02.046","article-title":"Prognostic value of preoperative left ventricular global longitudinal strain for predicting postoperative myocardial injury and mortality in patients undergoing major non-cardiac surgery (SOLOMON study)","volume":"378","author":"Kim","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_54","first-page":"133","article-title":"Perioperative Considerations in Metastatic Renal Cell Carcinoma","volume":"18","author":"Flavin","year":"2016","journal-title":"Rev. Urol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1002\/cncr.32991","article-title":"Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy","volume":"126","author":"McIntosh","year":"2020","journal-title":"Cancer"},{"key":"ref_56","first-page":"100751","article-title":"A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens","volume":"33","author":"Validyev","year":"2021","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","article-title":"Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy","volume":"17","author":"Cardinale","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaccao.2020.10.011","article-title":"Strain Imaging in Cardio-Oncology","volume":"2","author":"Liu","year":"2020","journal-title":"JACC CardioOncology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: An International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/clinpract13020035","article-title":"Potential Role of Global Longitudinal Strain in Cardiac and Oncological Patients Undergoing Cardio-Oncology Rehabilitation (CORE)","volume":"13","author":"Cuomo","year":"2023","journal-title":"Clin. Pract."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","article-title":"Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: An expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"S\u0142awi\u0144ski, G., Hawryszko, M., Li\u017cewska-Springer, A., Nabia\u0142ek-Trojanowska, I., and Lewicka, E. (2023). Global Longitudinal Strain in Cardio-Oncology: A Review. Cancers, 15.","DOI":"10.3390\/cancers15030986"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1200\/JCO.2011.37.1195","article-title":"Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors","volume":"30","author":"Schutz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1303989","article-title":"Pazopanib versus sunitinib in metastatic renal-cell carcinoma","volume":"369","author":"Motzer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1158\/1078-0432.CCR-15-0215","article-title":"Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805","volume":"21","author":"Haas","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/annonc\/mdn168","article-title":"Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate","volume":"19","author":"Telli","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e004408","DOI":"10.1161\/CIRCHEARTFAILURE.117.004408","article-title":"Longitudinal Assessment of Vascular Function with Sunitinib in Patients with Metastatic Renal Cell Carcinoma","volume":"11","author":"Catino","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Franczyk, B., Rysz, J., \u0141awi\u0144ski, J., Cia\u0142kowska-Rysz, A., and Gluba-Brz\u00f3zka, A. (2023). Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010181"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/bcp.13895","article-title":"Cabozantinib-related cardiotoxicity: A prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients","volume":"85","author":"Iacovelli","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchf.2012.09.001","article-title":"The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients","volume":"1","author":"Hall","year":"2013","journal-title":"JACC Heart Fail."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.critrevonc.2014.12.008","article-title":"Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"94","author":"Ghatalia","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12265-020-10042-3","article-title":"The Role of Biomarkers in Cardio-Oncology","volume":"13","author":"Ananthan","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Shalata, W., Abu-Salman, A., Steckbeck, R., Mathew Jacob, B., Massalha, I., and Yakobson, A. (2021). Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review. Cancers, 13.","DOI":"10.3390\/cancers13205218"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant Myocarditis with Combination Immune Checkpoint Blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ejhf.2289","article-title":"Cardiotoxicity associated with immune checkpoint inhibitor therapy: A meta-analysis","volume":"23","author":"Castillo","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e002435","DOI":"10.1136\/jitc-2021-002435","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","volume":"9","author":"Brahmer","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.21873\/anticanres.11152","article-title":"Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer","volume":"36","author":"Vesely","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_80","first-page":"395","article-title":"Four cardiac hormones cause death of human cancer cells but not of healthy cells","volume":"31","author":"Skelton","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2362.2006.01721.x","article-title":"Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers","volume":"36","author":"Vesely","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_82","first-page":"1459","article-title":"Family of peptides synthesized in the human body have anticancer effects","volume":"34","author":"Vesely","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2310\/JIM.0b013e3181948b25","article-title":"Cardiac and renal hormones: Anticancer effects in vitro and in vivo","volume":"57","author":"Vesely","year":"2009","journal-title":"J. Investig. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Mezzasoma, L., Talesa, V.N., Costanzi, E., and Bellezza, I. (2021). Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer. Biomolecules, 11.","DOI":"10.3390\/biom11060794"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.2174\/0929867328666201223124813","article-title":"Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma","volume":"28","author":"Zhang","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2174\/0929867321666140205140152","article-title":"Atrial natriuretic peptide: A magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators","volume":"21","author":"Serafino","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_87","first-page":"2409","article-title":"Central role of \u03b2-catenin in anticancer effects of cardiac hormones","volume":"33","author":"Skelton","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H1388","DOI":"10.1152\/ajpheart.00414.2002","article-title":"Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro","volume":"284","author":"Kook","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2362.2012.02695.x","article-title":"Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor","volume":"42","author":"Nguyen","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_90","first-page":"785","article-title":"Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones","volume":"33","author":"Skelton","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/eci.12153","article-title":"Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells","volume":"43","author":"Manimala","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2019.01.007","article-title":"Silencing of the Na+\/H+ exchanger 1(NHE-1) prevents cardiac structural and functional remodeling induced by angiotensin II","volume":"107","author":"Medina","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Fu, H., Zhang, J., Cai, Q., He, Y., and Yang, D. (2022). Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity. Cancers, 14.","DOI":"10.3390\/cancers14163981"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jtcvs.2011.09.003","article-title":"Effect of low-dose human atrial natriuretic peptide on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer: A double-blind, placebo-controlled study","volume":"143","author":"Nojiri","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/11\/1912\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:44:59Z","timestamp":1760125499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/11\/1912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":94,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["diagnostics13111912"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13111912","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}